Skip to main content
Erschienen in: Journal of Ophthalmic Inflammation and Infection 1/2020

Open Access 01.12.2020 | Letter to the Editor

Concurrent presence of retinal hemorrhages in the setting of acute Vogt-Koyanagi-Harada syndrome - an unusual presentation

verfasst von: Sowkath Ali, Hnin Hnin Oo, Rupesh Agarwal, Peh Khaik Khee

Erschienen in: Journal of Ophthalmic Inflammation and Infection | Ausgabe 1/2020

Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
VKH syndrome
Vogt-Koyanagi-Harada syndrome
RD
Retinal detachment
FFA
Fundus fluorescein angiogram
SS-OCT
Swept source optical coherence tomography
To the Editor,

Introduction

Vogt-Koyanagi-Harada syndrome (VKH), an autoimmune disorder, is an oculocutaneous meningeal syndrome commonly seen in pigmented race population characterized usually by bilateral granulomatous panuveitis, often associated with neurological, auditory, and cutaneous manifestations [1]. The incidence of VKH among Singaporean population in referral care centre was found to be 3% [2]. It usually presents in four phases—prodromal phase, acute uveitic phase, chronic or convalescent phase, and recurrent phase [3]. Exudative bilateral retinal detachments are usually noted in the acute uveitic phase which responds well to high dose of corticosteroids. The chronic or convalescent phase is characterized by the development of vitiligo, poliosis, and depigmentation of the choroid and usually occurs weeks after the acute uveitic phase [4]. The recurrent phase consists of a panuveitis with acute exacerbations of anterior uveitis [4]. We report a case of primary VKH syndrome in acute uveitic stage, with bilateral serous retinal detachment with multiple retinal hemorrhages which resolved completely with systemic corticosteroids. No specific cause for the presence of retinal hemorrhages was found, which also resolved with treatment. We present this case for its unusual presentation.

Case report

A 56-year-old lady was presented to the emergency clinic with acute onset of headache since 3 days followed by sudden progressive loss of vision in both eyes. No associated history of redness, photophobia, and floaters was noted. There was no evidence of any associated systemic illness. There was no uveitis-related systemic history in the form of joint pains, exposure to tuberculosis, exposure to pets, or fever with rashes. No previous history of any ocular surgery or trauma was noted. On examination, her best corrected visual acuity was counting fingers closely in both eyes; her intra ocular pressures were within normal limits. There was no relative afferent pupillary defect. Slit lamp examination showed anterior chamber reaction with cells occasionally in both eyes, no keratic precipitates were seen, lens was clear, and anterior vitreous face showed cells 1+ retrolentally. Fundus showed bilateral exudative retinal detachment with pockets of subretinal fluid in the posterior pole mainly superiorly and inferotemporally, with dot and blot hemorrhages seen around fovea, temporal to macula, and superior to disc. No evidence of vessel sheathing was seen (Fig. 1a, b).
Optical coherence tomography (OCT) macula showed areas of serous detachment (Fig. 2a) and RPE undulations with pockets of subretinal fluid (Fig. 2b). Fundus fluorescein angiography showed early blocked fluorescence with multiple pin-point leakages in the middle phases with placoid areas of hyperfluoresence in late phases (Fig. 3a, b). Clinical findings, OCT, and fluorescein angiography features are all typical of acute uveitic phase of VKH disease except for the presence of retinal hemorrhages. Differentials that were considered in our index case included leukemia, lymphoma, and syphilis. Magnetic resonance imaging (MRI) brain showed scattered foci of T2/FLAIR hyper intensities in the bilateral centrum semiovale, bilateral corona radiata, and subcortical and deep white matter of both frontal and parietal lobes. Full blood count was normal, and peripheral blood smear showed no significant morphologic abnormalities suggestive of hematopoietic tumor. Serological screen for syphilis, tuberculosis, and hepatitis viruses were negative.
In view of the typical angiographic features of acute uveitic stage of VKH syndrome, systemic corticosteroids were started in the form of intravenous methylprednisolone 1 g/day for 3 days followed by oral prednisolone 1 mg/kg along with topical steroids. Patient responded well to the treatment with resolution of the exudative retinal detachments as well as the hemorrhages (Fig. 4). On subsequent follow-up, her best corrected visual acuity improved to 6/9 in both eyes. She was on close follow-up.
We present this case the presence of retinal hemorrhages in the setting of acute VKH that is quite unusual in the absence of associated systemic diseases.

Discussion

The revised international classification of VKH is divided into incomplete, complete, and probable based on the systemic and ocular features [5]. Our index case did not have any skin, auditory, or neurological manifestations except for headache. MRI brain showed deep white matter lesions in the parietal lobes which were previously described as radiologic features of VKH syndrome [6]. She was found to have incomplete VKH syndrome based on the typical clinical and angiographic features in the absence of previous ocular surgery and trauma. However, presence of retinal hemorrhages was found to be unusual. Infective and hematological workup was within normal limits. There are case reports of atypical VKH syndrome noted in patients with leukemia [7, 8]. Choroidal infiltrations of leukemic cells with secondary RPE dysfunction can cause bilateral exudative retinal detachment mimicking VKH-like picture [9]. They can also present with auditory and neurological features as well as proliferative retinopathy with Roth spots, exudates, and hemorrhages. To our surprise, the peripheral smear was normal. Hence, we started the patient on high dose corticosteroids. Patient responded well with the resolution of both exudative retinal detachments and hemorrhages. We still cannot found out the cause of retinal hemorrhages and its resolution. Temporal association between retinal hemorrhages and VKH cannot be established in the index case; hence, the patient is in constant follow-up for any recurrences of same kind in the future. To our knowledge, retinal hemorrhages in acute uveitic phase of primary VKH syndrome are extremely rare. Retinal peripapillary hemorrhages along with optic disc edema have been previously reported in an observational case series of VKH syndrome in acute phase. Among 52 patients, 6 were found to have optic disc edema with hemorrhages secondary to anterior ischemic optic neuropathy [10]. Increase in retinal capillary fragility can occur in bullous rhegmatogenous detachment which can cause retinal hemorrhages, but our index case did show only few pockets of subretinal fluid which might not had increased the capillary fragility. Increase in venous pressure secondary to optic disc edema can also cause retinal hemorrhages, which was not found in our index case.

Conclusion

We present this case due to its unusual concurrent presentation of hemorrhages and exudative retinal detachment in the acute uveitic stage of primary VKH syndrome with no specific cause for hemorrhages and its resolution with treatment. We would need to observe the patient closely for future recurrences with same features and subsequent systemic workup. No temporal causal association has been found between the retinal hemorrhages and posterior uveitis in our index case.

Acknowledgements

Not applicable
Not Applicable
Written informed consent was obtained from the patient for publication of their individual details and accompanying images in this manuscript. The consent form is held by the authors in the patients’ clinical notes and is available for review by the Editor-in-Chief.

Competing interests

None of the authors have any financial or non-financial competing interest in the publication of the above manuscript.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Fang W, Yang P (2008) Vogt-Koyanagi-Harada syndrome. Curr Eye Res 33(7):517–517CrossRef Fang W, Yang P (2008) Vogt-Koyanagi-Harada syndrome. Curr Eye Res 33(7):517–517CrossRef
2.
Zurück zum Zitat Chen EJ et al (2018) Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) – report 1: epidemiology and classification. Ocul Immunol Inflamm 26(5):732–746CrossRef Chen EJ et al (2018) Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) – report 1: epidemiology and classification. Ocul Immunol Inflamm 26(5):732–746CrossRef
3.
Zurück zum Zitat O’Keefe, Datoo GA et al (2017) Vogt-Koyanagi-Harada disease. Surv Ophthalmol 62(1):1–25CrossRef O’Keefe, Datoo GA et al (2017) Vogt-Koyanagi-Harada disease. Surv Ophthalmol 62(1):1–25CrossRef
4.
Zurück zum Zitat Moorthy RS, Inomata H, Rao NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 39(4):265–292CrossRef Moorthy RS, Inomata H, Rao NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 39(4):265–292CrossRef
5.
Zurück zum Zitat Tugal-Tutkun I, Ozyazgan Y, Akova YA, Sullu Y, Akyol N, Soylu M et al (2007) The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol 27(2-3):117–123CrossRef Tugal-Tutkun I, Ozyazgan Y, Akova YA, Sullu Y, Akyol N, Soylu M et al (2007) The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol 27(2-3):117–123CrossRef
6.
Zurück zum Zitat Keles S, Ogul H, Pinar LC, Kantarci M (2013) Teaching neuroimages: cerebral white matter involvement in a patient with Vogt-Koyanagi-Harada syndrome. Neurology. 81(11):85–86CrossRef Keles S, Ogul H, Pinar LC, Kantarci M (2013) Teaching neuroimages: cerebral white matter involvement in a patient with Vogt-Koyanagi-Harada syndrome. Neurology. 81(11):85–86CrossRef
7.
Zurück zum Zitat AlZamil WM (2013) Lymphocytic leukemia presenting as acute Vogt-Koyanagi-Harada disease. Saudi J Ophthalmol. 28(4):319–321CrossRef AlZamil WM (2013) Lymphocytic leukemia presenting as acute Vogt-Koyanagi-Harada disease. Saudi J Ophthalmol. 28(4):319–321CrossRef
8.
Zurück zum Zitat Chawla R, Meena S, Tomar AS, Venkatesh P, Vohra R (2017) Vogt-Koyanagi-Harada disease in a patient of chronic myeloid leukemia. Indian J Ophthalmol. 65(5):411–413CrossRef Chawla R, Meena S, Tomar AS, Venkatesh P, Vohra R (2017) Vogt-Koyanagi-Harada disease in a patient of chronic myeloid leukemia. Indian J Ophthalmol. 65(5):411–413CrossRef
9.
Zurück zum Zitat Leonardy NJ, Rupani M, Dent G, Klintworth GK (1990) Analysis of 135 autopsy eyes for ocular involvement in leukemia. Am J Ophthalmol. 109:436–444CrossRef Leonardy NJ, Rupani M, Dent G, Klintworth GK (1990) Analysis of 135 autopsy eyes for ocular involvement in leukemia. Am J Ophthalmol. 109:436–444CrossRef
10.
Zurück zum Zitat Nakao K, Mizushima Y, Abematsu N, Goh N, Sakamoto T (2009) Anterior ischemic optic neuropathy associated with Vogt–Koyanagi–Harada disease. Graefe’s Arch Clin Exp Ophthalmol. 247:1417–1425CrossRef Nakao K, Mizushima Y, Abematsu N, Goh N, Sakamoto T (2009) Anterior ischemic optic neuropathy associated with Vogt–Koyanagi–Harada disease. Graefe’s Arch Clin Exp Ophthalmol. 247:1417–1425CrossRef
Metadaten
Titel
Concurrent presence of retinal hemorrhages in the setting of acute Vogt-Koyanagi-Harada syndrome - an unusual presentation
verfasst von
Sowkath Ali
Hnin Hnin Oo
Rupesh Agarwal
Peh Khaik Khee
Publikationsdatum
01.12.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Ophthalmic Inflammation and Infection / Ausgabe 1/2020
Elektronische ISSN: 1869-5760
DOI
https://doi.org/10.1186/s12348-020-00203-5

Weitere Artikel der Ausgabe 1/2020

Journal of Ophthalmic Inflammation and Infection 1/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.